North America Sepsis Diagnostics Market Size, Share & Industry Trends Analysis Report By Method, By Test Type, By Pathogen, By Product, By End-User, By Technology, By Country and Growth Forecast, 2022 - 2028

The North America Sepsis Diagnostics Market would witness market growth of 7.0% CAGR during the forecast period (2022-2028).

These data analytics technologies have made it possible to combine several test findings from many platforms, allowing for real-time access to data and precise detection of diseases. In addition, various technological advances have resulted in the development of novel immunological and molecular biomarkers that can be used to detect sepsis early. Following this, the market for sepsis diagnostics is being driven by increased investments in comprehensive R&D initiatives, which include innovative blood culture methodologies for diagnosing and treating chronic infections. Sepsis is a catastrophic situation that happens when one or more organs fail.

Rapid detection is very important for patient survival because the survival probability drops by a notable rate for every hour when antimicrobial therapy is delayed. Many of the SOFA criteria, such as blood analyzers, also necessitate facilities and testing equipment that may not be provided in improvement of the healthcare communities. Due to these limitations, a simpler, single test for diagnosing sepsis at the point of care that can substitute the SOFA score without lowering accuracy would be preferred.

Point of care (POC) thermal techniques on bimolecular analysis give a client or health professional immediately, actionable information at the time and location of assessment and treatment. These technologies are often low-cost, simple-to-use, and quick, with lesser infrastructure requirements, making them useful in a wide range of situations across the world. Small sample quantities, such as a fingerprick blood sample, portable standalone devices, as well as the most basic lab equipment, such as microscopes, are all possible with POC technology.

There is a substantial presence of a larger patient population as well as a growing geriatric population in this region. Moreover, this region comprises well-established insurance policies and a robust healthcare infrastructure.

According to Sepsis alliance, more than 1.7 million people in the United States are diagnosed with sepsis each year, one in every 20 seconds, and the incidence is increasing at an annual rate of 8%, with hospitalization costs in the United States exceeding USD 27 billion. According to statistics, the region's market growth is boosted by a growing patient population and high disposable income. Additionally, according to the Centers for Disease Control and Prevention, approximately 1.7 million adults in the United States were estimated to diagnose with sepsis in August 2021, with nearly 270,000 Americans dying as a result. It was also shown that sepsis affects one out of every 3 patients who die in a hospital. As a result of the high estimated incidence of the condition in the country, the market will benefit from increased diagnosis.

The US market dominated the North America Sepsis Diagnostics Market by Country in 2021, and would continue to be a dominant market till 2018; thereby, achieving a market value of $226.3 million by 2028. The Canada market is poised to grow at a CAGR of 9.5% during (2022 - 2028). Additionally, The Mexico market would display a CAGR of 8.5% during (2022 - 2028).

Based on Method, the market is segmented into Conventional and Automated. Based on Test Type, the market is segmented into Laboratory Tests and Point-of-Care Tests. Based on Pathogen, the market is segmented into Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, and Others. Based on Product, the market is segmented into Blood Culture Media, Assays & Reagents, Instruments, and Software. Based on End-User, the market is segmented into Hospitals & specialty clinics, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes. Based on Technology, the market is segmented into Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, and Biomarkers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

Free Valuable Insights: The Global Sepsis Diagnostics MarketMarket is Estimated to reach $879.5 Million by 2028, at a CAGR of 8.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Abbott Laboratories, Thermo Fisher Scientific, Inc., DiaSorin S.p.A., Bruker Corporation, Siemens Healthineers AG, Danaher Corporation, and Quidel Corporation.

Scope of the Study

Market Segments Covered in the Report:

By Method

• Conventional
• Automated

By Test Type

• Laboratory Tests
• Point-of-Care Tests

By Pathogen

• Bacterial Sepsis
• Fungal Sepsis
• Viral Sepsis
• Others

By Product

• Blood Culture Media
• Assays & Reagents
• Instruments
• Software

By End-User

• Hospitals & specialty clinics
• Pathology & Reference Laboratories
• Research Laboratories & Academic Institutes

By Technology

• Blood Culture
• Immunoassays
• Molecular Diagnostics
• Flow Cytometry
• Microfluidics
• Biomarkers

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• BioMérieux S.A.
• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson and Company
• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• DiaSorin S.p.A.
• Bruker Corporation
• Siemens Healthineers AG
• Danaher Corporation
• Quidel Corporation

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Sepsis Diagnostics Market, by Method
1.4.2 North America Sepsis Diagnostics Market, by Test Type
1.4.3 North America Sepsis Diagnostics Market, by Pathogen
1.4.4 North America Sepsis Diagnostics Market, by Product
1.4.5 North America Sepsis Diagnostics Market, by End-User
1.4.6 North America Sepsis Diagnostics Market, by Technology
1.4.7 North America Sepsis Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2021, Dec) Leading Players

Chapter 4. North America Sepsis Diagnostics Market by Method
4.1 North America Conventional Market by Country
4.2 North America Automated Market by Country

Chapter 5. North America Sepsis Diagnostics Market by Test Type
5.1 North America Laboratory Tests Market by Country
5.2 North America Point-of-Care Tests Market by Country

Chapter 6. North America Sepsis Diagnostics Market by Pathogen
6.1 North America Bacterial Sepsis Market by Country
6.2 North America Fungal Sepsis Market by Country
6.3 North America Viral Sepsis Market by Country
6.4 North America Others Market by Country

Chapter 7. North America Sepsis Diagnostics Market by Product
7.1 North America Blood Culture Media Market by Country
7.2 North America Assays & Reagents Market by Country
7.3 North America Instruments Market by Country
7.4 North America Software Market by Country

Chapter 8. North America Sepsis Diagnostics Market by End-User
8.1 North America Hospitals & specialty clinics Market by Country
8.2 North America Pathology & Reference Laboratories Market by Country
8.3 North America Research Laboratories & Academic Institutes Market by Country

Chapter 9. North America Sepsis Diagnostics Market by Technology
9.1 North America Blood Culture Market by Country
9.2 North America Immunoassays Market by Country
9.3 North America Molecular Diagnostics Market by Country
9.4 North America Flow Cytometry Market by Country
9.5 North America Microfluidics Market by Country
9.6 North America Biomarkers Market by Country

Chapter 10. North America Sepsis Diagnostics Market by Country
10.1 US Sepsis Diagnostics Market
10.1.1 US Sepsis Diagnostics Market by Method
10.1.2 US Sepsis Diagnostics Market by Test Type
10.1.3 US Sepsis Diagnostics Market by Pathogen
10.1.4 US Sepsis Diagnostics Market by Product
10.1.5 US Sepsis Diagnostics Market by End-User
10.1.6 US Sepsis Diagnostics Market by Technology
10.2 Canada Sepsis Diagnostics Market
10.2.1 Canada Sepsis Diagnostics Market by Method
10.2.2 Canada Sepsis Diagnostics Market by Test Type
10.2.3 Canada Sepsis Diagnostics Market by Pathogen
10.2.4 Canada Sepsis Diagnostics Market by Product
10.2.5 Canada Sepsis Diagnostics Market by End-User
10.2.6 Canada Sepsis Diagnostics Market by Technology
10.3 Mexico Sepsis Diagnostics Market
10.3.1 Mexico Sepsis Diagnostics Market by Method
10.3.2 Mexico Sepsis Diagnostics Market by Test Type
10.3.3 Mexico Sepsis Diagnostics Market by Pathogen
10.3.4 Mexico Sepsis Diagnostics Market by Product
10.3.5 Mexico Sepsis Diagnostics Market by End-User
10.3.6 Mexico Sepsis Diagnostics Market by Technology
10.4 Rest of North America Sepsis Diagnostics Market
10.4.1 Rest of North America Sepsis Diagnostics Market by Method
10.4.2 Rest of North America Sepsis Diagnostics Market by Test Type
10.4.3 Rest of North America Sepsis Diagnostics Market by Pathogen
10.4.4 Rest of North America Sepsis Diagnostics Market by Product
10.4.5 Rest of North America Sepsis Diagnostics Market by End-User
10.4.6 Rest of North America Sepsis Diagnostics Market by Technology

Chapter 11. Company Profiles
11.1 BioMérieux S.A.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Acquisition and Mergers:
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Approvals and Trials:
11.3 Becton, Dickinson and Company
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 Recent strategies and developments:
11.3.5.1 Product Launches and Product Expansions:
11.4 Abbott Laboratories
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 Recent strategies and developments:
11.4.5.1 Acquisition and Mergers:
11.5 Thermo Fisher Scientific, Inc.
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Approvals and Trials:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 DiaSorin S.p.A. (Luminex Corporation)
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Research & Development Expenses
11.6.5 Recent strategies and developments:
11.6.5.1 Acquisitions and Mergers:
11.7 Bruker Corporation
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Product Launches and Product Expansions:
11.7.5.2 Acquisition and Mergers:
11.8 Siemens Healthineers AG (Siemens AG)
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental and Regional Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Partnerships, Collaborations, and Agreements:
11.8.5.2 Acquisition and Mergers:
11.9 Danaher Corporation
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.10. Quidel Corporation
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Regional Analysis
11.10.4 Research & Development Expense
11.10.5 Recent strategies and developments:
11.10.5.1 Acquisition and Mergers:

TABLE 1 North America Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 North America Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Sepsis Diagnostics Market
TABLE 4 Product Launches And Product Expansions – Sepsis Diagnostics Market
TABLE 5 Acquisition and Mergers – Sepsis Diagnostics Market
TABLE 6 Approvals and Trials – Sepsis Diagnostics Market
TABLE 7 North America Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 8 North America Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 9 North America Conventional Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Conventional Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Automated Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Automated Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 14 North America Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 15 North America Laboratory Tests Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Laboratory Tests Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Point-of-Care Tests Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Point-of-Care Tests Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 20 North America Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 21 North America Bacterial Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Bacterial Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Fungal Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Fungal Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Viral Sepsis Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Viral Sepsis Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 30 North America Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 31 North America Blood Culture Media Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Blood Culture Media Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Assays & Reagents Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Assays & Reagents Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Instruments Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Instruments Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Software Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Software Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 40 North America Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 41 North America Hospitals & specialty clinics Market by Country, 2018 - 2021, USD Million
TABLE 42 North America Hospitals & specialty clinics Market by Country, 2022 - 2028, USD Million
TABLE 43 North America Pathology & Reference Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 44 North America Pathology & Reference Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 45 North America Research Laboratories & Academic Institutes Market by Country, 2018 - 2021, USD Million
TABLE 46 North America Research Laboratories & Academic Institutes Market by Country, 2022 - 2028, USD Million
TABLE 47 North America Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 48 North America Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 49 North America Blood Culture Market by Country, 2018 - 2021, USD Million
TABLE 50 North America Blood Culture Market by Country, 2022 - 2028, USD Million
TABLE 51 North America Immunoassays Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Immunoassays Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Flow Cytometry Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Flow Cytometry Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Microfluidics Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Microfluidics Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Biomarkers Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Biomarkers Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Sepsis Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 62 North America Sepsis Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 63 US Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 64 US Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 65 US Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 66 US Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 67 US Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 68 US Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 69 US Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 70 US Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 71 US Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 72 US Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 73 US Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 74 US Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 75 US Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 76 US Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 77 Canada Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 78 Canada Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 79 Canada Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 80 Canada Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 81 Canada Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 82 Canada Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 83 Canada Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 84 Canada Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 85 Canada Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 86 Canada Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 87 Canada Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 88 Canada Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 89 Canada Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 90 Canada Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 91 Mexico Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 92 Mexico Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 93 Mexico Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 94 Mexico Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 95 Mexico Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 96 Mexico Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 97 Mexico Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 98 Mexico Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 99 Mexico Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 100 Mexico Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 101 Mexico Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 102 Mexico Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 103 Mexico Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 104 Mexico Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 105 Rest of North America Sepsis Diagnostics Market, 2018 - 2021, USD Million
TABLE 106 Rest of North America Sepsis Diagnostics Market, 2022 - 2028, USD Million
TABLE 107 Rest of North America Sepsis Diagnostics Market by Method, 2018 - 2021, USD Million
TABLE 108 Rest of North America Sepsis Diagnostics Market by Method, 2022 - 2028, USD Million
TABLE 109 Rest of North America Sepsis Diagnostics Market by Test Type, 2018 - 2021, USD Million
TABLE 110 Rest of North America Sepsis Diagnostics Market by Test Type, 2022 - 2028, USD Million
TABLE 111 Rest of North America Sepsis Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 112 Rest of North America Sepsis Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 113 Rest of North America Sepsis Diagnostics Market by Product, 2018 - 2021, USD Million
TABLE 114 Rest of North America Sepsis Diagnostics Market by Product, 2022 - 2028, USD Million
TABLE 115 Rest of North America Sepsis Diagnostics Market by End-User, 2018 - 2021, USD Million
TABLE 116 Rest of North America Sepsis Diagnostics Market by End-User, 2022 - 2028, USD Million
TABLE 117 Rest of North America Sepsis Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 118 Rest of North America Sepsis Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 119 Key information – BioMérieux S.A.
TABLE 120 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 121 Key information – Becton, Dickinson and Company
TABLE 122 Key Information – Abbott Laboratories
TABLE 123 Key Information – Thermo Fisher Scientific, Inc.
TABLE 124 Key Information – DiaSorin S.p.A.
TABLE 125 Key Information – Bruker Corporation
TABLE 126 Key Information – Siemens Healthineers AG
TABLE 127 Key Information – Danaher Corporation
TABLE 128 key information – Quidel Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2021, Dec) Leading Players
FIG 5 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 6 Swot analysis: thermo fisher scientific, inc.
FIG 7 Recent strategies and developments: Bruker Corporation